A Study to Assess the Efficacy and Safety of REL-1017 as Monotherapy for Major Depressive Disorder (MDD)
Clinical trial NCT05081167 · COMPLETED
Trial details
- NCT number
- NCT05081167
- Sponsor
- Relmada Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-02
- Primary completion
- 2022-09-13
- Enrollment
- 232
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.